Muraglitazar is a Peroxime Proliferator Activated (PPAR) Agonist that has glucose- and lipid-lowering activities. It is used for the treatment of Type-2 Diabetes Mellitus, Mixed Dyslipidemia, Atherosclerosis, and Metabolic Syndrome (Dual (alpha and gamma). Muraglitazar improves glycaemic control by enhancing insulin sensitivity and β cell function in T2DM (Type 2 Diabetes Mellitus) subjects, improves multiple cardiovascular risk factors, reduces muscle, visceral and hepatic fat content in T2DM subjects.

Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months.
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.